Galantamine for treatment-resistant schizophrenia

被引：45

作者：

Allen, TB

McEvoy, JP

机构：

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2002年 / 159卷 / 07期

关键词：

D O I：

10.1176/appi.ajp.159.7.1244

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：1244 / 1245

页数：2

共 6 条

[1] Schizophrenia, sensory gating, and nicotinic receptors [J].

Adler, LE ;

Olincy, A ;

Waldo, M ;

Harris, JG ;

Griffith, J ;

Stevens, K ;

Flach, K ;

Nagamoto, H ;

Bickford, P ;

Leonard, S ;

Freedman, R .

SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202

[2] Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors [J].

Arias, HR .

NEUROCHEMISTRY INTERNATIONAL, 2000, 36 (07) :595-645

[3]

HUANG F, IN PRESS J CLIN PHAR

[4] Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease [J].

Maelicke, A ;

Albuquerque, EX .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :165-170

[5] Smoking and therapeutic response to clozapine in patients with schizophrenia [J].

McEvoy, JP ;

Freudenreich, O ;

Wilson, WH .

BIOLOGICAL PSYCHIATRY, 1999, 46 (01) :125-129

[6] Gating of auditory P50 in schizophrenics: Unique effects of clozapine [J].

Nagamoto, HT ;

Adler, LE ;

Hea, RA ;

Griffith, JM ;

McRae, KA ;

Freedman, R .

BIOLOGICAL PSYCHIATRY, 1996, 40 (03) :181-188

← 1 →